Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

BackgroundWith the widespread use of next-generation sequencing (NGS) in clinical practice, an increasing number of biomarkers that predict a response to anti-tumor therapy in non-small cell lung cancer (NSCLC) has been identified. However, validated biomarkers that can be used to detect a response...

Full description

Bibliographic Details
Main Authors: Linlin Zhang, Shasha Guan, Fanlu Meng, Lin Teng, Diansheng Zhong
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
NGS
homologous recombination
platinum sensitivity
chemotherapy
NSCLC
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1035808/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1035808/full

Similar Items